US Stock MarketDetailed Quotes

Moderna (MRNA)

Watchlist
  • 39.360
  • -1.220-3.01%
Close Jan 15 16:00 ET
  • 39.420
  • +0.060+0.15%
Post 20:01 ET
15.38BMarket Cap-4.88P/E (TTM)

Moderna (MRNA) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
-45.98%1B
-38.01%137M
-35.93%107M
-52.64%3.2B
-66.01%956M
3.81%1.86B
-30.06%221M
-90.91%167M
-64.22%6.75B
-45.37%2.81B
Operating revenue
-33.50%1.97B
-7.85%176M
-52.70%105M
-44.93%4.52B
-73.64%1.14B
68.70%2.96B
-34.81%191M
-87.86%222M
-55.50%8.2B
-10.99%4.33B
Cost of revenue
-59.73%207M
3.48%119M
-6.25%90M
-68.80%1.46B
-20.45%739M
-77.06%514M
-84.27%115M
-87.88%96M
-13.35%4.69B
-51.56%929M
Gross profit
-40.72%795M
-83.02%18M
-76.06%17M
-15.82%1.74B
-88.48%217M
395.37%1.34B
125.54%106M
-93.21%71M
-84.69%2.06B
-41.69%1.88B
Operating expense
-25.23%1.06B
-37.03%925M
-20.19%1.07B
-9.84%5.68B
-22.10%1.46B
-9.44%1.41B
1.17%1.47B
-5.31%1.34B
55.98%6.3B
13.75%1.88B
Selling and administrative expenses
-4.63%268M
-14.18%230M
-22.63%212M
-24.21%1.17B
-25.32%351M
-36.43%281M
-19.28%268M
-10.16%274M
36.84%1.55B
25.33%470M
Research and development costs
-29.55%801M
-42.67%700M
-19.47%856M
-6.23%4.54B
-20.20%1.12B
-1.98%1.14B
6.36%1.22B
-6.01%1.06B
47.04%4.85B
16.10%1.41B
Other operating expenses
-100.00%-14M
75.00%-5M
---1M
60.64%-37M
-600.00%-10M
84.09%-7M
28.57%-20M
----
75.77%-94M
-96.92%2M
Operating profit
-271.43%-260M
33.46%-907M
17.06%-1.05B
6.94%-3.95B
-20,866.67%-1.25B
96.52%-70M
27.00%-1.36B
-245.90%-1.27B
-145.00%-4.24B
-99.62%6M
Net non-operating interest income expense
-24.74%73M
-23.81%80M
-21.93%89M
4.70%401M
-12.37%85M
2.11%97M
15.38%105M
14.00%114M
91.50%383M
-8.49%97M
Non-operating interest income
-29.13%73M
-27.03%81M
-25.00%90M
0.95%425M
-11.65%91M
-1.90%103M
6.73%111M
10.09%120M
110.50%421M
18.39%103M
Non-operating interest expense
--0
-83.33%1M
-83.33%1M
-36.84%24M
0.00%6M
-40.00%6M
-53.85%6M
-33.33%6M
--38M
--6M
Other net income (expense)
142.86%9M
76.92%-3M
26.74%-63M
30.30%-23M
85.37%-6M
-177.78%-21M
66.67%-13M
-91.11%-86M
-6.45%-33M
Gain on sale of security
144.44%4M
----
53.33%-7M
22.22%-56M
59.09%-9M
75.68%-9M
-204.55%-23M
57.14%-15M
---72M
---22M
Other non- operating income (expenses)
-233.33%-4M
350.00%9M
100.00%4M
50.00%-7M
-27.27%-14M
175.00%3M
-60.00%2M
150.00%2M
68.89%-14M
77.55%-11M
Income before tax
-990.48%-187M
36.04%-818M
17.25%-964M
8.50%-3.61B
-1,791.43%-1.18B
101.07%21M
26.87%-1.28B
-281.97%-1.17B
-141.17%-3.94B
-95.77%70M
Income tax
62.50%13M
7M
-30.00%7M
-105.96%-46M
56.46%-64M
-99.52%8M
0
102.60%10M
-36.36%772M
-177.37%-147M
Net income
-1,638.46%-200M
35.50%-825M
17.36%-971M
24.46%-3.56B
-616.13%-1.12B
100.36%13M
7.32%-1.28B
-1,587.34%-1.18B
-156.37%-4.71B
-85.19%217M
Net income continuous Operations
-1,638.46%-200M
35.50%-825M
17.36%-971M
24.46%-3.56B
-616.13%-1.12B
100.36%13M
7.32%-1.28B
-1,587.34%-1.18B
-156.37%-4.71B
-85.19%217M
Minority interest income
Net income attributable to the parent company
-1,638.46%-200M
35.50%-825M
17.36%-971M
24.46%-3.56B
-616.13%-1.12B
100.36%13M
7.32%-1.28B
-1,587.34%-1.18B
-156.37%-4.71B
-85.19%217M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-1,638.46%-200M
35.50%-825M
17.36%-971M
24.46%-3.56B
-616.13%-1.12B
100.36%13M
7.32%-1.28B
-1,587.34%-1.18B
-156.37%-4.71B
-85.19%217M
Basic earnings per share
-1,800.00%-0.51
36.04%-2.13
17.92%-2.52
24.74%-9.28
-610.53%-2.91
100.31%0.03
8.01%-3.33
-1,635.00%-3.07
-158.00%-12.33
-85.04%0.57
Diluted earnings per share
-1,800.00%-0.51
36.04%-2.13
17.92%-2.52
24.74%-9.28
-629.09%-2.91
100.31%0.03
8.01%-3.33
-1,715.79%-3.07
-161.28%-12.33
-84.76%0.55
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue -45.98%1B-38.01%137M-35.93%107M-52.64%3.2B-66.01%956M3.81%1.86B-30.06%221M-90.91%167M-64.22%6.75B-45.37%2.81B
Operating revenue -33.50%1.97B-7.85%176M-52.70%105M-44.93%4.52B-73.64%1.14B68.70%2.96B-34.81%191M-87.86%222M-55.50%8.2B-10.99%4.33B
Cost of revenue -59.73%207M3.48%119M-6.25%90M-68.80%1.46B-20.45%739M-77.06%514M-84.27%115M-87.88%96M-13.35%4.69B-51.56%929M
Gross profit -40.72%795M-83.02%18M-76.06%17M-15.82%1.74B-88.48%217M395.37%1.34B125.54%106M-93.21%71M-84.69%2.06B-41.69%1.88B
Operating expense -25.23%1.06B-37.03%925M-20.19%1.07B-9.84%5.68B-22.10%1.46B-9.44%1.41B1.17%1.47B-5.31%1.34B55.98%6.3B13.75%1.88B
Selling and administrative expenses -4.63%268M-14.18%230M-22.63%212M-24.21%1.17B-25.32%351M-36.43%281M-19.28%268M-10.16%274M36.84%1.55B25.33%470M
Research and development costs -29.55%801M-42.67%700M-19.47%856M-6.23%4.54B-20.20%1.12B-1.98%1.14B6.36%1.22B-6.01%1.06B47.04%4.85B16.10%1.41B
Other operating expenses -100.00%-14M75.00%-5M---1M60.64%-37M-600.00%-10M84.09%-7M28.57%-20M----75.77%-94M-96.92%2M
Operating profit -271.43%-260M33.46%-907M17.06%-1.05B6.94%-3.95B-20,866.67%-1.25B96.52%-70M27.00%-1.36B-245.90%-1.27B-145.00%-4.24B-99.62%6M
Net non-operating interest income expense -24.74%73M-23.81%80M-21.93%89M4.70%401M-12.37%85M2.11%97M15.38%105M14.00%114M91.50%383M-8.49%97M
Non-operating interest income -29.13%73M-27.03%81M-25.00%90M0.95%425M-11.65%91M-1.90%103M6.73%111M10.09%120M110.50%421M18.39%103M
Non-operating interest expense --0-83.33%1M-83.33%1M-36.84%24M0.00%6M-40.00%6M-53.85%6M-33.33%6M--38M--6M
Other net income (expense) 142.86%9M76.92%-3M26.74%-63M30.30%-23M85.37%-6M-177.78%-21M66.67%-13M-91.11%-86M-6.45%-33M
Gain on sale of security 144.44%4M----53.33%-7M22.22%-56M59.09%-9M75.68%-9M-204.55%-23M57.14%-15M---72M---22M
Other non- operating income (expenses) -233.33%-4M350.00%9M100.00%4M50.00%-7M-27.27%-14M175.00%3M-60.00%2M150.00%2M68.89%-14M77.55%-11M
Income before tax -990.48%-187M36.04%-818M17.25%-964M8.50%-3.61B-1,791.43%-1.18B101.07%21M26.87%-1.28B-281.97%-1.17B-141.17%-3.94B-95.77%70M
Income tax 62.50%13M7M-30.00%7M-105.96%-46M56.46%-64M-99.52%8M0102.60%10M-36.36%772M-177.37%-147M
Net income -1,638.46%-200M35.50%-825M17.36%-971M24.46%-3.56B-616.13%-1.12B100.36%13M7.32%-1.28B-1,587.34%-1.18B-156.37%-4.71B-85.19%217M
Net income continuous Operations -1,638.46%-200M35.50%-825M17.36%-971M24.46%-3.56B-616.13%-1.12B100.36%13M7.32%-1.28B-1,587.34%-1.18B-156.37%-4.71B-85.19%217M
Minority interest income
Net income attributable to the parent company -1,638.46%-200M35.50%-825M17.36%-971M24.46%-3.56B-616.13%-1.12B100.36%13M7.32%-1.28B-1,587.34%-1.18B-156.37%-4.71B-85.19%217M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -1,638.46%-200M35.50%-825M17.36%-971M24.46%-3.56B-616.13%-1.12B100.36%13M7.32%-1.28B-1,587.34%-1.18B-156.37%-4.71B-85.19%217M
Basic earnings per share -1,800.00%-0.5136.04%-2.1317.92%-2.5224.74%-9.28-610.53%-2.91100.31%0.038.01%-3.33-1,635.00%-3.07-158.00%-12.33-85.04%0.57
Diluted earnings per share -1,800.00%-0.5136.04%-2.1317.92%-2.5224.74%-9.28-629.09%-2.91100.31%0.038.01%-3.33-1,715.79%-3.07-161.28%-12.33-84.76%0.55
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More